New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
07:13 EDTDCTHDelcath Systems announces reimbursement for Chemostat in Chermany
Delcath Systems announced that the Institut für das Entgeltsystem im Krankenhaus, the German federal reimbursement agency, has established a reimbursement pathway for the treatment of patients with liver metastases with the Delcath Hepatic CHEMOSAT Delivery System for melphalan hydrochloride. The Value 4 status given to the CHEMOSAT procedure, while not mandating reimbursement, allows participating cancer centers to negotiate reimbursement coverage for the CHEMOSAT procedure with all insurers serving their region. Under the NUB scheme, reimbursement pathways will potentially be available for treatment with CHEMOSAT regardless of primary cancer origin.
News For DCTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
17:03 EDTDCTHMitchell Kopin reports 6.7% passive stake in Delcath Systems
July 20, 2015
08:07 EDTDCTHDelcath Systems's melphalan granted Orphan Drug Designation by FDA
Delcath Systems announced that the FDA Office of Orphan Products Development, or OOPD, has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma. The OOPD is tasked with evaluating the scientific and clinical data submissions from sponsors to identify and designate products as promising for rare diseases and to further advance scientific development of such promising medical products.
July 16, 2015
09:15 EDTDCTHDelcath Systems raises $6.2M n a common stock and warrant offering
Subscribe for More Information
July 15, 2015
09:03 EDTDCTHDelcath Systems treatment of cholangiocarcinoma granted orphan status
Subscribe for More Information
July 14, 2015
07:04 EDTDCTHAntares Pharma names Peter Graham SVP, chief compliance officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use